Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613000996763Phase 4Completed
Phase 4 trial of lidocaine in None, sponsored by University of Toronto. Primary endpoint: Pain during laser treatment. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613000996763.